Journal
NATURE CHEMICAL BIOLOGY
Volume 18, Issue 9, Pages 981-+Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41589-022-01072-w
Keywords
-
Categories
Funding
- DARPA Soils [HR00111920019]
- Welch [F-1654]
- AFSOR [FA9550-14-1-0089]
- National Institutes of Health [R01GM104896, R01GM125882]
Ask authors/readers for more resources
Researchers have developed a combination of screening and selection methods to evolve specific and sensitive biosensors for therapeutic plant metabolites production. They successfully streamlined the pathway for tetrahydropapaverine and provided a more efficient method for the synthesis of four modern pharmaceuticals.
A key bottleneck in the microbial production of therapeutic plant metabolites is identifying enzymes that can improve yield. The facile identification of genetically encoded biosensors can overcome this limitation and become part of a general method for engineering scaled production. We have developed a combined screening and selection approach that quickly refines the affinities and specificities of generalist transcription factors; using RamR as a starting point, we evolve highly specific (>100-fold preference) and sensitive (half-maximum effective concentration (EC50) <30 mu M) biosensors for the alkaloids tetrahydropapaverine, papaverine, glaucine, rotundine and noscapine. High-resolution structures reveal multiple evolutionary avenues for the malleable effector-binding site and the creation of new pockets for different chemical moieties. These sensors further enabled the evolution of a streamlined pathway for tetrahydropapaverine, a precursor to four modern pharmaceuticals, collapsing multiple methylation steps into a single evolved enzyme. Our methods for evolving biosensors enable the rapid engineering of pathways for therapeutic alkaloids.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available